Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer
Open Access
- 1 January 2013
- journal article
- Published by Springer Science and Business Media LLC in Journal of Nanobiotechnology
- Vol. 11 (1), 4
- https://doi.org/10.1186/1477-3155-11-4
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectivesNanoscale, 2011
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatmentBMC Cancer, 2011
- Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery systemInternational Journal of Nanomedicine, 2011
- Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancerBreast Cancer Research, 2011
- Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapyJournal of Nanobiotechnology, 2011
- Tamoxifen−Poly(ethylene glycol)−Thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer TreatmentBioconjugate Chemistry, 2009
- Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft modelsMolecular Cancer Therapeutics, 2009
- Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applicationsDalton Transactions, 2009
- Comparative clinical study of canine and feline total blood cell count results with seven in‐clinic and two commercial laboratory hematology analyzersVeterinary Clinical Pathology, 2008
- Nanotechnology-based drug delivery systemsJournal of Occupational Medicine and Toxicology, 2007